Detalles de la búsqueda
1.
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Circulation
; 143(12): 1215-1223, 2021 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33461308
2.
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
N Engl J Med
; 380(16): 1509-1524, 2019 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30883055
3.
[Dual antiplatelet therapy after acute coronary syndrome or percutaneous coronary intervention: with what and for how long?] / Duale Thrombozytenhemmung nach akutem Koronarsyndrom oder perkutaner Koronarintervention womit und wie lange?
Internist (Berl)
; 62(11): 1243-1252, 2021 Nov.
Artículo
en Alemán
| MEDLINE | ID: mdl-34633479
4.
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Circulation
; 140(23): 1921-1932, 2019 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31557056
5.
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Lancet
; 392(10152): 1036-1046, 2018 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30158069
6.
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
N Engl J Med
; 372(25): 2387-97, 2015 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26039521
7.
An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial.
Am Heart J
; 200: 17-23, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29898844
8.
Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial.
Am Heart J
; 197: 1-8, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29447769
9.
Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.
Circulation
; 140(23): 1960-1963, 2019 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31553201
10.
Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX).
Crit Care Med
; 43(1): 57-64, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25083980
11.
Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.
JAMA
; 313(11): 1113-21, 2015 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25781440
12.
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.
Circulation
; 128(3): 237-43, 2013 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23770747
13.
Apixaban with antiplatelet therapy after acute coronary syndrome.
N Engl J Med
; 365(8): 699-708, 2011 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21780946
14.
Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF).
Europace
; 16(1): 6-14, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24084680
15.
[New direct oral oral anticoagulants (DOACs) - indications of DOACs]. / Indikationen für die DOAK.
Anasthesiol Intensivmed Notfallmed Schmerzther
; 49(3): 182-90; quiz 191, 2014 Mar.
Artículo
en Alemán
| MEDLINE | ID: mdl-24711238
16.
Event rates and risk factors for venous thromboembolism and major bleeding in a population of hospitalized adult patients with acute medical illness receiving enoxaparin thromboprophylaxis.
Eur J Intern Med
; 121: 48-55, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38030465
17.
Independent predictors of bleeding complications in patients undergoing PCI with concomitant treatment with bivalirudin in clinical practice results from the ImproveR registry.
J Cardiovasc Pharmacol
; 62(6): 507-11, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24072173
18.
Outcomes After Left Main Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock (from the German ALKK PCI Registry).
Am J Cardiol
; 197: 77-83, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37173201
19.
Imaging Predictors of Left Ventricular Functional Recovery after Reperfusion Therapy of ST-Elevation Myocardial Infarction Assessed by Cardiac Magnetic Resonance.
J Cardiovasc Dev Dis
; 10(7)2023 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37504550
20.
Dabigatran versus warfarin in patients with atrial fibrillation.
N Engl J Med
; 361(12): 1139-51, 2009 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-19717844